• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Zydus Names Nitin Parekh as Special Projects President

    INDPHARMAPOST

    Zydus, Synthon Ink Exclusive Licensing Deal for Ozanimod Capsules

    PR NEWSWIRE

    Zydus Introduces VaxiFlu, India`s 1st Trivalent Influenza Vaccine

    EXPRESSPHARMA

    Zydus launches VaxiFlu vaccine for flu protection

    INDPHARMAPOST

    Zydus Therapeutics Reports Phase-3 Results in Rare Liver Disease

    INDPHARMAPOST

    Zydus Lifesciences Hosts Health Symposium on New WHO Guideline

    EXPRESSPHARMA

    Zydus Lifesciences Q1 FY26 Net Profit Hits Rs. 1,466.8 Cr

    INDPHARMAPOST

    Zydus Gets USFDA Approval for Diltiazem Hydrochloride Tablets

    INDPHARMAPOST

    Zydus Gets USFDA Approval for Prucalopride Tablets

    INDPHARMAPOST

    Zydus`s Generics Diltiazem Hydrochloride Receives Approval in US

    FDA

    Health Canada Grants Zydus NOC for ZDS-Varenicline Tablets

    INDPHARMAPOST

    Delhi HC Denies Zydus Plea to Withhold Sigrima Process

    PHARMABIZ

    Zydus Challenges Order Restricting Cancer Drug Production

    ECONOMICTIMES

    Zydus Gets Tentative USFDA Approval for Ibrutinib Tablets

    INDPHARMAPOST

    USFDA Tentatively Approves Zydus Lifesciences` Generic Blood

    ECONOMICTIMES

    Zydus Life`s Plans for Cancer Biosimilar Hit a Legal Hurdle

    ECONOMICTIMES

    Zydus Gets USFDA Approval for Celecoxib Capsules

    INDPHARMAPOST

    USFDA ends inspection at Zydus` oncology plant in Ahmedabad

    INDPHARMAPOST

    Zydus gets EIR for API facility at Ankleshwar & Dabhasa

    INDPHARMAPOST

    Zydus Partners with Agenus for Cancer Therapies in India

    BUSINESSWIRE

    Zydus to acquire Agenus` U.S. facilities for biologics CDMO

    PR NEWSWIRE

    Zydus gets USFDA nod for Generic IBS-D treatment drug

    ECONOMICTIMES

    Zydus gets USFDA Fast Track for oral inhibitor Usnoflast

    INDPHARMAPOST

    Zydus Lifescience Updates Breast Cancer Awareness Campaign

    EXPRESSPHARMA

    Zydus` Breast Cancer Awareness Campaign Reaches Million

    INDPHARMAPOST

    Zydus Receives Final Approval from Fda for Isotretinoin Capsules

    INDPHARMAPOST

    Zydus developing single pen for adjustable Semaglutide doses

    ECONOMICTIMES

    Zydus Life`s profit rises on new US drug launches

    REUTERS

    Zydus receives approval from FDA for Glatiramer Acetate Injection

    INDPHARMAPOST

    Zydus Receives Approval From FDA for Glatiramer Acetate Injection

    BUSINESSWIRE

    Zydus Lifesciences completes 25 years of listing on NSE

    INDPHARMAPOST

    Zydus Lifesciences Chairman Pankaj Patel receives Padma Bhushan

    EXPRESSPHARMA

    Zydus Lifesciences approved by USFDA for generic cholesterol Drug

    ECONOMICTIMES

    USFDA inspection at Zydus` API Unit in Dabhasa, Gujarat ends

    INDPHARMAPOST

    Zydus Lifesciences to acquire 85.6 % stake in Amplitude Surgical

    INDPHARMAPOST

    Zydus gets 6 observations from USFDA for API unit

    ECONOMICTIMES

    Zydus Medtech partners Braile Biomedica for TAVI technology

    INDPHARMAPOST

    Indian Pharma firms Expand in US Cancer Generics Market

    BUSINESS STD

    Zynext Ventures invests in Feldan Therapeutics for drug delivery

    PR NEWSWIRE

    Enforcement Report - Week of April 16, 2025

    FDA

    Zydus Lifesciences receives FDA Approval for DMD treatment drug

    INDPHARMAPOST

    Pharma Companies Rush to Develop Weight-loss Drug Semaglutide

    ECONOMICTIMES

    Sentynl Therapeutics: Clinical Evidence for Nulibry in Molybdenum

    BUSINESSWIRE

    Zydus gets USFDA nod to produce prostate cancer treatment

    ECONOMICTIMES

    Enforcement Report - Week of March 12, 2025

    FDA

    Zynext Ventures Invests In Illexcor’s Sickle Cell Drug Development

    PR NEWSWIRE

    Zydus Lifesciences to buy 86% stake in French medical devices maker

    REUTERS

    Zydus Lifesciences launches ANVIMO

    INDPHARMAPOST

    Zydus, Gates Foundation To Develop Shigellosis-Typhoid Vaccine

    INDPHARMAPOST

    Zydus to develop combination vaccine for shigellosis and typhoid

    ECONOMICTIMES

    Zydus Launches India`s First Flu Vaccine For 2025 South Strain

    EXPRESSPHARMA

    Zydus to launch protection against new strain of influenza virus

    INDPHARMAPOST

    Pharma sector can deliver 100 new drugs by 2047: Zydus chairman

    BUSINESS STD

    Nifty Pharma Tanks 3% on Tariff Threat; Zydus, Lupin Down 10%

    BUSINESS STD

    Zydus Lifesciences inks licensing Pact with Zhuhai for Cancer

    ECONOMICTIMES

    Zydus signs agreement with Synthon for 505(B)(2) oncology product

    EXPRESS PHARMA

    Zydus Lifesciences posts Q3 FY25 net profit higher at Rs 1,024 Cr

    INDPHARMAPOST

    Pankaj Patel Of Zydus Lifesciences Receives Padma Bhushan

    EXPRESSPHARMA

    Zydus receives FDA Orphan Drug Designation for ALS

    ECONOMICTIMES

    Zydus Adds Zituvio™, Zituvimet™ To CVS Caremark Formulary

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.